BioSciKin international start-up competition for life sciences companies
6:30pm - 10:30pm PDT
BioSciKin, a China-based open investment and incubation platform, in collaboration with Simcere Pharma and other Chinese investors, have announced an international start-up competition for life sciences companies, with a preliminary track in San Francisco. The contest will be held in 8 cities, in the US as well as in China. Winners in each preliminary will receive $30,000 in non-dilutive financing, with the top two companies from each region receiving a paid trip to Shanghai to present in front of Chinese investors.
San Francisco Bay Area Startup Competition Preliminary
Date: April 7th, 2016 (Thursday)
Time: 6:30pm – 10:30pm PST (light dinner provided)
Address: Stanford University, Room130, Li Ka Shing Learning and Knowledge Center, 291 Campus Drive, Stanford, CA 94305.
How to Enter: send a non-confidential executive summary or no more than 10 slides along with your contact information to http://www.cabsweb.org/cabs-business-plan-contest/
Who Can Participate: The event welcomes both companies and entrepreneurial teams in life science area.
Application deadline: 15 March 2016
Organized by: Chinese American Biopharmaceutical Society (CABS) and Association of Chinese Students and Scholars at Stanford (ACSSS)
Supporting organization：California Life Sciences Institute (CLSI)
Dr. Lin Wu
Dr Lin Wu is Vice President, Development for the Sequencing Business Unit of Roche Diagnostics. Dr. Wu has strong background in IVD assay development and registration. She led the development of the first microarray-based pharmacogenetic assay approved by the FDA, AmpliChip CYP450, and assumed various leadership roles during the development of the cobas oncology portfolio. Dr. Wu pioneered the scientific research work in detecting tumor DNA in blood, which eventually led the launch of cobas EGFR blood assay. This work was the first recipient of Roche Diagnostic DIAmond Award for R&D Innovation.Dr. Lin Wu received her Ph. D. in Molecular Biology from State University of New York at Buffalo. Prior joining Roche, she completed her post-doctoral fellowship in cancer biology at Princeton University.
Panel of Judges:
Pete Thomas is a Managing Director of PointGuard Ventures(PGV). Prior to co-founding PointGuard Ventures, Pete co-founded ATA Ventures in 2004, a firm that raised $440M in capital across three funds during the last ten years. ATA has invested in over 40 early stage companies and Pete was on the board and directly involved in 11 of those companies and is presently on the board of Revera, Lavante, and Adesto Technologies and is an advisor to Theranos.
Kris panu is a Managing Director of PointGuard Ventures(PGV). For more than two decades Krish has built successful technology businesses which have created multi-billion dollar markets. Prior to entering the venture capital industry, Krish has held executive positions in several influential companies including @Road, Inc., Atmel, Catalyst Semiconductor, Datapoint Corporation and Xicor etc.
Dr. Roger Wyse is the Managing Partner of Spruce Capital Partners and BAR Capital Management. He chairs or serves on the boards of 11 private companies. He is Co-Chairman of the $162M Malaysian Life Sciences Capital Fund. He is also an internationally recognized scientist and was a Dean at 2 major research universities. He was founder and Chairman of the Alliance for Animal Genome Research. He is on Board of Industrial Section of BIO.
Dr. Luke Li has 30 years of experience in biopharma and healthcare business. Currently, Dr. Li is a Managing Director at Ally Bridge Group (“ABG”), a global healthcare investment platform. Before joining ABG, Dr. Li has held Executive positions at Pfizer and Amgen. He was an Assistant Professor in Medicine at Washington University Medical School.
Jason Wen is the Director of Technology Transfer at Boston College. He has a broad background combining experience in the life sciences, business, and patent law. Dr. Wen is a long time member of the Association of University Technology Managers (AUTM) and the Licensing Executives Society (LES). He is also a Registered Technology Transfer Professional (RTTP) and a United States Patent and Trademark Office Registered Patent Agent.
Sanofi North America’s Head of External Science and Partnering on East Coast.
Other judges include delegates from BioSciKin
BioSciKin is actively seeking investment opportunities in precision medicine filed and has made more than 10 investments over past two years in US, Korea and China, with typically investment size ranging from 0.5 million to 10 million USD.
Contact: Ms Ruikun Zhang
Contact Email: email@example.com
Stanford University, Room130, Li Ka Shing Learning and Knowledge Center, 291 Campus Drive, Stanford, CA 94305.